Table: monthly_update_prescription_drug_wac_inc , manufacturer_name like D*

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  *

oshpd_id manufacturer_name date_reported ndc_number drug_product_description wac_effective_date wac_increase_amount wac_after_increase patent_expiration_date drug_source_type unit_sales_volume_in_us unit_sales_volume_non_public_indicator gross_sales_us_dollars gross_sales_us_dollars_non_public_indicator cost_increase_factors cost_increase_factors_non_public_indicator change_improvement_description change_improvement_non_public_indicator acquisition_date company_acquired_from acquisition_price acquisition_price_non_public_indicator acquisition_price_comment wac_at_acquisition wac_year_prior_to_acquisition year_drug_introduced_to_market wac_at_intro_to_market supporting_documents general_comments
Rx0000081 Daiichi Sankyo, Inc. 04/15/2025 65597040601 Enhertu Intravenous Solution Reconstituted 100 MG 1 vial 01/01/2025 126.38 2934.75 12/20/2033 Single Source Drug None None None 1 None 1 None 1 None None None None None None None None None None None
Rx0000216 Deciphera Pharmaceuticals, LLC 04/25/2025 73207010130 Qinlock Oral Tablet 50 MG, 90 Each, Bottle 01/01/2025 1485.00 43470.00 10/06/2042 Single Source Drug None None None 1 The establishment of price and associated price changes may take into consideration a number of factors such as current market dynamics, competitive environment, the clinical and economic value of therapy, therapeutic category, payer environment, government rebates, patient support, overall research and development costs, as well as business operational continuation needs. In our commitment to patients and ensuring patient access, we have a patient support program that provides reimbursement and financial assistance programs for eligible patients. None None 1 None None None None None None None None None None None
Rx0000492 Dynavax Technologies Corporation 02/21/2025 43528000305 HEPLISAV-B™ [Hepatitis B Vaccine (Recombinant)] Adjuvanted 20 MCG / 0.5 ML PFS. 5 syringes/carton 01/15/2025 40.60 778.75 04/16/2032 Innovator Multiple Source Drug None None 392831796 None Planned increase is due to increasing business costs and inflationary effects. None There is no change or improvement that necessitated the price increase. None None None None None None None None None None None None